Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Idec commences phase I/II study with IDEC-114 for treatment of psoriasis

Oct. 7, 1999

BMS and Gillette seek approval for Vaniqa in the U.S.

Oct. 7, 1999

Abgenix completes phase I/II clinical trial with ABX-IL-8

Oct. 6, 1999

Antiallergic agents described by Senju in recently issued patent

Sep. 30, 1999

Results of phase III becaplermin study in pressure ulcers are inconsistent with phase II findings

Sep. 29, 1999

Roche presents antiproliferative retiferol derivatives particularly useful for psoriasis

Sep. 29, 1999

Kanebo discloses preparation and use of new selectin inhibitors

Sep. 27, 1999

Switch Biotech awarded grant for wound-healing therapies

Sep. 21, 1999

CXCR1/CXCR2 receptor antagonists a focus of research at Warner-Lambert

Sep. 17, 1999

Warner-Lambert discloses new IL-8 (CXCR1/CXCR2) receptor antagonists

Sep. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...